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Introduction: Although the use of negative pressure wound therapy (NPWT) is broadly
efﬁcacious, it may foster some potentially adverse complications. This is particularly
true in patients with diabetes who have a wound colonized with aerobic organisms.
Traditional antiseptics have been proven useful to combat such bacteria but require
removal of some NPWT devices to be effective. Methods: In this article, we describe
a method of “wound chemotherapy” by combining NPWT and a continuous infusion
of Dakins’ 0.5% solution either as a standardized technique in one device (ITI Sved)
or as a modiﬁcation of standard technique in another (KCI VAC) NPWT device. The
twin goals of both techniques are to effectively reduce bacterial burden and to promote
progressive wound healing. Results: We present several representative case examples
of our provisional experience with continuous streaming therapy through 2 foam-based
negative pressure devices. Discussion: Wound chemotherapy was successfully applied
to patients with diabetes, without adverse reactions, complications, or recolonization
during the course of treatment. We believe this to be a promising method to derive the
beneﬁts of NPWT without the frequent adverse sequela of wound colonization.
Negative pressure wound therapy (NPWT) is frequently employed to achieve wound
simpliﬁcation and closure in patients with diabetes.1 The application of a vacuum device is
simple and automatically maintains a negative pressure environment, conducive for wound
healing.2,3
One of the problems we have noted in our extensive experience with NPWT in
very complex and chronic wounds has been the development of wound colonization and
subsequent maceration. When used for extended periods, such a bacterial burden could
necessitate VAC device removal and discontinuation of NPWT.4 Although in vitro studies
of silver-impregnated foam dressings have shown promise, further evidence from in vivo
trials is needed.5 In our previous experience with such dressings, we have not managed to
reduce bacterial burden to our satisfaction.
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Previous authors, most notably Fleischmann and colleagues, as well as Svedman,
have discussed the infusion of a variety of substances into the wound.6-12 The work of
Fleischmann led to the development of a “VAC Instill” device, which consists of a VAC
port and an infusion port with 2 “stopcocks” to allow for separate infusion and vacuum
periods. This process involves a “hold” cycle during which ﬂuid is infused into the foam
during a pause in NPWT.
On the basis of our experience, the use of the latter device poses 3 difﬁculties:
(1) VAC Instill therapy system has not been readily or rapidly available to many units;
(2) the programmed “hold sequence” often potentiates maceration of the wound and its
margins; and (3) the quality of dressing seal appears to be compromised by stagnant
irrigation.
TheSvedmanconceptinvolvescontinuousinfusion,or“streaming,”withsimultaneous
NPWT and is realized in a commercially available device (Sved; Innovative Therapies,
Inc [ITI], Gaithersburg, Md). This streaming concept is attractive for the aforementioned
reasons. The ITI Sved unit works by means of a constant vacuum drainage mechanism,
whereby an infusion or instillation catheter is connected to a secondary port in the foam
dressing. Because both an infusion of therapeutic agents and a signiﬁcant reduction in
wound margin macerations can be achieved without compromise of dressing seal integrity,
the Sved device has shown some promising preliminary results. However, access to this
device has been difﬁcult in our unit and others.
To address these issues we have identiﬁed with the standard VAC and the VAC Instill
as well as the lack of availability of the ITI Sved device and modiﬁed the KCI VAC device
to permit continuous streaming infusion using equipment found in any healthcare setting.
In addition to the standard drainage port, a secondary port is installed on the opposite side
of the vacuum tubing to insert an intravenous (IV) infusion catheter. This interface is then
sealed with additional dressing over the foam.
In the following cases, we describe the use of ITI Sved and modiﬁed KCI VAC
devices, with a chemotherapeutic 0.5% Dakins’ (dilute hypochlorous acid) solution, to
achieve wound healing and closure.13-15 Foam dressings were reapplied every other day
with an infusion rate of approximately 30 mL/h. Debridement of wound margins, base, and
exposed bone were performed as necessary (Fig 1).
CASE STUDIES
Case 1
A 60-year-old man with diabetes mellitus presented with an infection caused primarily by
methicillin-resistant Staphylococcus aureus and underwent an open-Chopart amputation of
his right foot. While on KCI VAC therapy, he developed heavy wound colonization with
Pseudomonas aeruginosa.
After a series of surgical debridements and 2 autologous split-thickness skin grafts,
Sved device therapy was initiated with an infusion of Dakins’ solution. Substitution of a
KCI VAC was utilized to allow for a larger collection canister while maintaining the ITI
Sved infusion catheter.
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Figure 1. Four images to exemplify the devices, dressings,
and modiﬁcations used in this study. (a) ITI Sved foam
dressing with an infusion and drainage port; (b) a modiﬁed
KCI VAC dressing with an intravenous (IV) pump infusion
catheter; (c) KCI VAC with Sved infusion catheter; and (d)a
modiﬁed KCI VAC foam dressing with an IV pump infusion
catheter.
Reinfection from Pseudomonas or any other pathogens did not occur while Dakins’
solution as an infusion medium was administered from a modiﬁed KCI VAC or Sved over
the span of 26 days until the application of the ultimate split-thickness skin graft.
Case 2
A 40-year-old woman with diabetes mellitus presented following a Chopart-level amputa-
tion and failed free ﬂap of her left foot. While undergoing KCI VAC therapy, she developed
a colonized wound; wound cultures grew Pseudomonas. This colonization and periwound
maceration necessitated discontinuation of the VAC device.
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After multiple surgical debridements and drainage procedures, the application of a
modiﬁed KCI VAC device and dressing with a Dakins’ IV solution as an infusion medium
via IV pump was performed. While receiving Dakins’ solution as an infusion medium with
NPWT over a 16-day follow-up course that included 5 days in hospital and 11 days in
home therapy, reinfection with Pseudomonas did not reoccur. The wound was prepared for
split-thickness skin grafting and healing by secondary intention.
Case 3
A 65-year-old man with diabetes and a history of left above-knee amputation was seen
in the outpatient clinic with an ischemic ulcer over his right medial malleolus. He had
previously undergone a cryovein (cadaveric vein conduit) bypass and multiple free ﬂaps
without successful healing or wound closure.
Previous therapy with conventional NPWT resulted in wound colonization with Pseu-
domonas,necessitatingdiscontinuationoftheVAC.Afteraseriesofsurgicaldebridements,
an ITI Sved device with Dakins’ solution as an infusion medium was applied. This patient
was monitored over the course of 16 days (3 days as inpatient and 13 days at home).
Pseudomonas colonization did not recur while NPWT with Dakins’ solution as an infusion
medium was maintained. His wound was well prepared for a subsequent split-thickness
skin graft.
Case 4
A 56-year-old man with diabetes and delayed healing of a transmetatarsal amputation
underwent multiple revascularization and debidement procedures. Previous application of
anunmodiﬁedKCIVACtherapydeviceresultedincolonizationandeventualPseudomonas
infection. Surgical debridement was performed, followed by the application of a modiﬁed
KCI VAC dressing with an IV infusion pump.
During the time of infusion with NPWT via Dakins’ solution, his wound did not
become reinfected or suffer any further with ischemic necrosis. The patient’s wound was
well prepared for a subsequently successful split-thickness skin graft.
OUTCOMES
All4patientssufferedfromchronic,complex,diabeticextremitywounds,previousamputa-
tions,andfailedstandardNPWTtherapy.NPWTfailurewasduetocolonizationandslough
replete with Pseudomonas species and required discontinuation of therapy. When NPWT
treatment combined with a continuous infusion of Dakins’ 0.5% solution was initiated,
reinfection or recolonization of the wounds did not occur (Figs 2 and 3).
Surgical debridements were performed as necessary during dressing changes at the
bedside or in the operating suite. The combined use of Dakins’ solution as an infusion
medium and NPWT did not appear to adversely impact wound healing rates; in fact, they
appeared to be accentuated during the period of evaluation (Fig 4).
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Figure 2. Examples of cases 1 to 4 before wound chemotherapy treatment: (a) case 1; (b) case
2; (c) case 3; and (d) case 4.
DISCUSSION
The use of NPWT alone may, in some patients, promote a change in the wound microbiota
and result in the colonization that can impede healing. The cyclical instillation, hold, and
drainage of therapeutic ﬂuids with a “VAC Instill” device pose several problems including
wound maceration and loss of dressing seal. The use of streaming Dakins’ solution as an
infusionmediumappearstoresolvemanyoftheseproblems.Webelievethatthepossibilities
for streaming therapy through NPWT to be broad and not simply limited to antimicrobials.
Modalities such as analgesics, cytokines, angiogenic factors, and anti-inﬂammatory agents
may also prove fruitful in the future.
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Figure 3. Examples of cases 1 to 4 after wound chemotherapy treatment for the number of
followed days: (a) case 1; (b) case 2; (c) case 3; and (d) case 4.
To our knowledge, the combination or modiﬁcation of vacuum devices to per-
mit continuous Dakins’ solution as an infusion medium has not been previously pub-
lished. Although further research is necessary to ascertain the true value of Dakins’
solution as an infusion medium or any such infusion into NPWT devices, we believe
wound-based chemotherapy should be considered for a place in the treatment spec-
trum of complex wounds. The possibility of standardizing and streamlining the de-
livery of targeted therapies is not only attractive but also necessary as we move to-
ward more controlled therapeutic regimens. We anticipate further developments in this
area.
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Figure 4. A 3-step method for the modiﬁcation of a standard VAC foam dressing with a standard
disposable suture removal kit. (a) Step 1: The initial slit in the dressing using scissors and
countersinkingofunderlyingfoamusingtweezerstoaccommodatetheinterfaceoftheintravenous
(IV) tubing. (b) Step 2: Insertion of the IV tubing interface into the foam through the covering
dressing. (c) Step 3: The application of dressing seal around the IV tubing.
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